UK markets closed
  • FTSE 100

    6,630.52
    -20.36 (-0.31%)
     
  • FTSE 250

    20,961.31
    -334.92 (-1.57%)
     
  • AIM

    1,163.26
    -10.13 (-0.86%)
     
  • GBP/EUR

    1.1607
    +0.0010 (+0.09%)
     
  • GBP/USD

    1.3834
    -0.0060 (-0.43%)
     
  • BTC-GBP

    35,520.77
    +36.39 (+0.10%)
     
  • CMC Crypto 200

    982.93
    +39.75 (+4.21%)
     
  • S&P 500

    3,841.94
    +73.47 (+1.95%)
     
  • DOW

    31,496.30
    +572.16 (+1.85%)
     
  • CRUDE OIL

    66.28
    +2.45 (+3.84%)
     
  • GOLD FUTURES

    1,698.20
    -2.50 (-0.15%)
     
  • NIKKEI 225

    28,864.32
    -65.78 (-0.23%)
     
  • HANG SENG

    29,098.29
    -138.50 (-0.47%)
     
  • DAX

    13,920.69
    -135.65 (-0.97%)
     
  • CAC 40

    5,782.65
    -48.00 (-0.82%)
     

Correction: DNA’s Financial Statements Bulletin 2020

DNA Oyj
·2-min read

DNA PLC STOCK EXCHANGE RELEASE 5 FEBRUARY 2021, 11:30 AM EET

DNA Plc published its Financial Statement Bulletin 2020 on 2 February 2021. The Group contribution was incorrectly reported in the consolidated income statement (net impact EUR 10.5 million), even though it should have been reported in the balance sheet as a deduction of retained earnings (equity).

Correction of the error does not affect DNA's EBITDA or operating result.

Corrected key figures:

EUR million

7-12/2020

7-12/2019

Change, %

1-12/2020

1-12/2019

Change, %

Net result before tax

72

59

21

143

125

15

Net result for the period

59

47

24

115

99

16

Return on investment (ROI), %

13

12

13

12

Return on equity (ROE), %

19

17

19

17

Basic and diluted earnings per share, EUR

0,45

0,36

0,87

0,75

Incorrect figures were:

EUR million

7-12/2020

7-12/2019

Change, %

1-12/2020

1-12/2019

Change, %

Net result before tax

59

59

-1

130

125

5

Net result for the period

48

47

2

104

99

6

Return on investment (ROI), %

12

12

12

12

Return on equity (ROE), %

17

17

17

17

Basic and diluted earnings per share, EUR

0.37

0.36

0.79

0.75

Corrected Financial Statement Bulletin 2020 in its entirety attached.

Additional information:
Jukka Leinonen, CEO, DNA Plc, +358 44 044 1000, jukka.leinonen@dna.fi
Maria Strömberg, CFO, DNA Plc, tel. +358 44 044 3270, maria.stromberg@dna.fi
DNA Corporate Communications, +358 44 044 8000, viestinta@dna.fi

DNA is one of the leading telecommunications companies in Finland. We want to make our customers' daily lives less complicated. We offer connections, services and devices for homes and workplaces, contributing to the digitalisation of society. DNA's customers are continuously among the world mobile data usage leaders. DNA has more than 4 million subscriptions in its fixed and mobile communications networks. The company has been awarded numerous times as an excellent employer and family-friendly workplace. In 2020, our total revenue was EUR 934 million and we employ about 1,600 people around Finland. DNA is a part of Telenor Group, a leading telecommunications company across the Nordics. More information: www.dna.fi, Twitter @DNA_fi, Facebook @DNA.fi and LinkedIn @DNA-Oyj.

Attachment